TARS compared with CMPS: revenue, margins and what each company keeps, and the suppliers and customers both name

TARSTarsus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

CMPSCOMPASS Pathways plc

Mkt capRevenueRevenue

Compare

TARSTarsus Pharmaceuticals, Inc.

CMPSCOMPASS Pathways plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TARS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.5%▲+6.59%×0.63

Q1 FY26±13.4%▼−1.24%×0.09

Feb 24 '26±14.8%▲+7.79%×0.53

Nov 5 '25±13.3%▼−4.62%×0.35

CMPS

No earnings history for CMPS.

= impliedTARS realized, solidCMPS realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

TARSTarsus Pharmaceuticals, Inc.

74.85▲+0.88%· post 75.94

Mkt cap$3.3BRevenue$174MQ2 FY26Revenue$451MFY25

CMPSCOMPASS Pathways plc

11.57▼−5.09%· post 11.62

ClosedOct 30 '26

Mkt cap$1.6BRevenue—Revenue—

Compare

ClosedOct 30 '26

TARSTarsus Pharmaceuticals, Inc.

CMPSCOMPASS Pathways plc

74.85▲+0.88%post 75.94

Price

11.57▼−5.09%post 11.62

$3.3B

Mkt cap

$1.6B

Q2 FY26$174M

Revenue

—

FY25$451M

Revenue

—

TARS74.85▲+0.88%vsCMPS11.57▼−5.09%ClosedOct 30 '26